Free Trial

Abeona Therapeutics (ABEO) News Today

Abeona Therapeutics logo
$6.41
+0.05 (+0.79%)
(As of 10/31/2024 ET)
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $15.00 price target on shares of Abeona Therapeutics in a report on Thursday.
Abeona Therapeutics completes Pz-cel BLA resubmission to U.S. FDA
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Reaffirmed by Cantor Fitzgerald
Cantor Fitzgerald restated an "overweight" rating and issued a $18.00 price target on shares of Abeona Therapeutics in a research note on Tuesday.
Rosalind Advisors, Inc. Expands Stake in Myomo Inc
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50-Day Moving Average - What's Next?
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above Fifty Day Moving Average - Here's What Happened
Abeona Therapeutics Inc stock logo
Renaissance Technologies LLC Grows Stake in Abeona Therapeutics Inc (NASDAQ:ABEO)
Renaissance Technologies LLC grew its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 581.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 503,293 shares of the biopharmaceutical company's stock after buyin
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Sees Significant Drop in Short Interest
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 2,630,000 shares, a decrease of 7.4% from the August 31st total of 2,840,000 shares. Currently, 6.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 301,300 shares, the short-interest ratio is currently 8.7 days.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics' (ABEO) "Overweight" Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating and set a $18.00 price target on shares of Abeona Therapeutics in a research note on Friday.
Abeona Therapeutics Inc stock logo
Simplify Asset Management Inc. Makes New $1.73 Million Investment in Abeona Therapeutics Inc (NASDAQ:ABEO)
Simplify Asset Management Inc. bought a new stake in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 408,584 shares of the biopharmaceutical company's stock, valued at a
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Sees Large Decrease in Short Interest
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 2,840,000 shares, a decrease of 6.3% from the August 15th total of 3,030,000 shares. Currently, 7.3% of the shares of the company are sold short. Based on an average trading volume of 348,000 shares, the short-interest ratio is currently 8.2 days.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Stock Passes Below 200-Day Moving Average of $5.49
Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average of $5.49
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Above Fifty Day Moving Average of $5.08
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50-Day Moving Average of $5.08
Abeona Therapeutics Inc stock logo
StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell
StockNews.com lowered Abeona Therapeutics from a "hold" rating to a "sell" rating in a research note on Monday.
Abeona Therapeutics Inc stock logo
Research Analysts Offer Predictions for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at Zacks Small Cap raised their FY2024 earnings estimates for Abeona Therapeutics in a report released on Wednesday, August 14th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will earn ($1.33
Abeona Therapeutics Inc stock logo
Q3 2024 Earnings Estimate for Abeona Therapeutics Inc Issued By HC Wainwright (NASDAQ:ABEO)
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Abeona Therapeutics in a research note issued to investors on Wednesday, August 14th. HC Wainwright analyst R. Selvaraju now expects that the bi
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $15.00 price target on shares of Abeona Therapeutics in a research report on Wednesday.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to "Hold" by StockNews.com
StockNews.com upgraded Abeona Therapeutics from a "sell" rating to a "hold" rating in a research note on Tuesday.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average of $5.58
Abeona Therapeutics (NASDAQ:ABEO) Stock Passes Below Two Hundred Day Moving Average of $5.58
0H7R.IL,0P0001H727,0 (0H7R.IL)
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) to Post Q3 2024 Earnings of ($0.36) Per Share, HC Wainwright Forecasts
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright issued their Q3 2024 EPS estimates for Abeona Therapeutics in a research report issued on Wednesday, July 3rd. HC Wainwright analyst R. Selvaraju forecasts that the biopharmaceutical company will post earnings p
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Now Covered by HC Wainwright
HC Wainwright began coverage on shares of Abeona Therapeutics in a research report on Wednesday. They issued a "buy" rating and a $15.00 price target for the company.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Down 24.2% in May
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 2,290,000 shares, a decrease of 24.2% from the May 15th total of 3,020,000 shares. Approximately 5.8% of the company's stock are sold short. Based on an average trading volume of 712,100 shares, the short-interest ratio is currently 3.2 days.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Shares Cross Below 50-Day Moving Average of $5.27
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below 50-Day Moving Average of $5.27
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated by Analysts at Stifel Nicolaus
Stifel Nicolaus began coverage on shares of Abeona Therapeutics in a research report on Thursday. They set a "buy" rating and a $21.00 target price for the company.
Abeona Therapeutics Inc stock logo
Q2 2024 EPS Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO) Lifted by Analyst
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Zacks Small Cap raised their Q2 2024 earnings per share estimates for Abeona Therapeutics in a research report issued on Tuesday, May 28th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will post earnings of
ABEO: BLA Resubmission in 2H24
Abeona Therapeutics Inc stock logo
AIGH Capital Management LLC Has $3.95 Million Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)
AIGH Capital Management LLC decreased its holdings in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 30.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 787,769 shares of the biopharmaceutical company's stock
Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

Banking failure dead ahead (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

ABEO Media Mentions By Week

ABEO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABEO
News Sentiment

0.21

0.68

Average
Medical
News Sentiment

ABEO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABEO Articles
This Week

8

2

ABEO Articles
Average Week

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners